Skip to main content

Table 3 Factors investigated for correlation with CDI (n = 122)

From: Polymerase chain reaction ribotyping of Clostridium difficileisolates in Qatar: a hospital-based study

Correlating factors Infected with CDI N = 122 (%) Correlating ribotypes
PPI use* 65 (53.3%) 014, 258, 046,053, 017 and 001
Age ≥ 65 yr 41 (33.6%) 107, 001,103, 011,116, 126,015, 017, 183, 186, 003,046, 053, 056, 078, 081, 084
Medicinal steroid use* 29 (23.7%) 258, 014, 001,106, 107, 015, 016, 183, 193, 353, 046, 081, 095
NSAID* 28 (23%) 107, 258, 011, 103, 014, 174, 183,193, 020, 353, 004, 046, 056, 081, 084, 087
Immunosupression 25 (20.5%) 014, 015, 046 , 258, 001,106, 116, 016,017, 183, 186, 193, 353
Chemotherapy* 18 (14.7%) 046, 001, 106, 116, 014,183,186, 193, 216, 258,003, 353
CKD 17 (14%) 011, 116,126, 014, 017, 174, 046, 078, 084
CLD 5 (4.1%) 183, 186, 003
Organ-transplant 4 (3.3%) 011
IBD 1 (0.8%) 015, 056
  1. *PPI: Proton Pump Inhibitor; NSAID: Non-steroidal anti-inflammatory drug; IBD: Inflammatory bowel disease; CKD: Chronic kidney disease; CLD: Chronic liver disease.
  2. All treatments were administered up to 3 months prior to acquiring CDI.
  3. NS: Non-significant.